Product Code: GVR-4-68038-458-1
Optical Preclinical Imaging Market Growth & Trends:
The global optical preclinical imaging market size is expected to reach USD 805.6 million by the end of 2030, expanding at a CAGR of 4.2%, according to a new report by Grand View Research, Inc. Increasing number of preclinical studies aimed to study and develop various effective therapeutics for different diseases is a major factor boosting the adoption of optical preclinical imaging systems.
For instance, in December 2018, Bugworks Research, a drug discovery startup based in India, received US$ 3 million grant from CARB-X, a Boston-based organization. The grant was offered to support the development of preclinical trail for novel molecules to fight antimicrobial resistance. Moreover, various researchers are engaged in finding novel ways to increase the reproducibility and robustness of preclinical cancer research with an aim to reduce the failure rate of oncology clinical trials. Optical imaging also allows cost-effective and high-throughput animal study as compared to small animal molecular imaging technologies, including PET and MRI systems.
Optical Preclinical Imaging Market Report Highlights:
- North America accounted for the largest share in 2024 owing to well-established research infrastructure, adoption of guidelines for preclinical research, product approvals, and higher number of drug development projects
- Based on product type, in the device segment, bioluminescence captured the largest optical preclinical imaging market share in 2024 owing to high sensitivity and broad dynamic range as compared to other techniques for imaging animals used in various studies
- By end use, the pharma and biotech companies segment accounted for the largest optical preclinical imaging market share in 2024 owing to increasing number of candidates in drug development studies and increasing focus on research and development for drug development and innovation
- The research institutes segment is expected to witness the fastest growth during the forecast period owing to rising adoption of advanced optical imaging systems in the research institutes
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Optical Preclinical Imaging Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
Chapter 4. Optical Preclinical Imaging Market: Product Business Analysis
- 4.1. Product Market Share, 2024 & 2030
- 4.2. Product Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Device
- 4.4.1. Device Market, 2018 - 2030 (USD Million)
- 4.4.2. Fluorescence
- 4.4.2.1. Fluorescence Market, 2018 - 2030 (USD Million)
- 4.4.3. Bioluminescence
- 4.4.3.1. Bioluminescence Market, 2018 - 2030 (USD Million)
- 4.5. Consumables
- 4.5.1. Consumables Market, 2018 - 2030 (USD Million)
- 4.5.2. Fluorescence
- 4.5.2.1. Fluorescence Market, 2018 - 2030 (USD Million)
- 4.5.2.2. Green Fluorescent Proteins
- 4.5.2.2.1. Green Fluorescent Proteins Market, 2018 - 2030 (USD Million)
- 4.5.2.3. Red Fluorescent Proteins
- 4.5.2.3.1. Red Fluorescent Proteins Market, 2018 - 2030 (USD Million)
- 4.5.2.4. Infrared Dyes
- 4.5.2.4.1. Infrared Dyes Market, 2018 - 2030 (USD Million)
- 4.5.2.5. Others
- 4.5.2.5.1. Others Market, 2018 - 2030 (USD Million)
- 4.5.3. Bioluminescence
- 4.5.3.1. Bioluminescence Market, 2018 - 2030 (USD Million)
- 4.5.3.2. Luciferins
- 4.5.3.2.1. Luciferins Market, 2018 - 2030 (USD Million)
- 4.5.3.3. Proluciferins
- 4.5.3.3.1. Proluciferins Market, 2018 - 2030 (USD Million)
- 4.5.3.4. Coelenterazine
- 4.5.3.4.1. Coelenterazine Market, 2018 - 2030 (USD Million)
- 4.5.3.5. Others
- 4.5.3.5.1. Others Market, 2018 - 2030 (USD Million)
- 4.6. Software
- 4.6.1. Software Market, 2018 - 2030 (USD Million)
Chapter 5. Optical Preclinical Imaging Market: End Use Business Analysis
- 5.1. End Use Market Share, 2024 & 2030
- 5.2. End Use Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 5.4. Pharma and Biotech Companies
- 5.4.1. Pharma and Biotech Companies Market, 2018 - 2030 (USD Million)
- 5.5. Research Institutes
- 5.5.1. Research Institutes Market, 2018 - 2030 (USD Million)
- 5.6. Others
- 5.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Optical Preclinical Imaging Market: Regional Estimates & Trend Analysis by Product and End Use
- 6.1. Regional Market Share Analysis, 2024 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.4. North America
- 6.4.1. North America Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.4.2. U.S.
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Regulatory Framework
- 6.4.2.3. Competitive Insights
- 6.4.2.4. U.S. Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Canada
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Regulatory Framework
- 6.4.3.3. Competitive Insights
- 6.4.3.4. Canada Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. Mexico
- 6.4.4.1. Key Country Dynamics
- 6.4.4.2. Regulatory Framework
- 6.4.4.3. Competitive Insights
- 6.4.4.4. Mexico Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5. Europe
- 6.5.1. Europe Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.5.2. UK
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Regulatory Framework
- 6.5.2.3. Competitive Insights
- 6.5.2.4. UK Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Germany
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Regulatory Framework
- 6.5.3.3. Competitive Insights
- 6.5.3.4. Germany Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.4. France
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Regulatory Framework
- 6.5.4.3. Competitive Insights
- 6.5.4.4. France Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.5. Italy
- 6.5.5.1. Key Country Dynamics
- 6.5.5.2. Regulatory Framework
- 6.5.5.3. Competitive Insights
- 6.5.5.4. Italy Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.6. Spain
- 6.5.6.1. Key Country Dynamics
- 6.5.6.2. Regulatory Framework
- 6.5.6.3. Competitive Insights
- 6.5.6.4. Spain Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.7. Norway
- 6.5.7.1. Key Country Dynamics
- 6.5.7.2. Regulatory Framework
- 6.5.7.3. Competitive Insights
- 6.5.7.4. Norway Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.8. Denmark
- 6.5.8.1. Key Country Dynamics
- 6.5.8.2. Regulatory Framework
- 6.5.8.3. Competitive Insights
- 6.5.8.4. Denmark Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.9. Sweden
- 6.5.9.1. Key Country Dynamics
- 6.5.9.2. Regulatory Framework
- 6.5.9.3. Competitive Insights
- 6.5.9.4. Sweden Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6. Asia Pacific
- 6.6.1. Asia Pacific Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.6.2. Japan
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Regulatory Framework
- 6.6.2.3. Competitive Insights
- 6.6.2.4. Japan Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. China
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Regulatory Framework
- 6.6.3.3. Competitive Insights
- 6.6.3.4. China Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. India
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Regulatory Framework
- 6.6.4.3. Competitive Insights
- 6.6.4.4. India Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. South Korea
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Regulatory Framework
- 6.6.5.3. Competitive Insights
- 6.6.5.4. South Korea Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.6. Australia
- 6.6.6.1. Key Country Dynamics
- 6.6.6.2. Regulatory Framework
- 6.6.6.3. Competitive Insights
- 6.6.6.4. Australia Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.7. Thailand
- 6.6.7.1. Key Country Dynamics
- 6.6.7.2. Regulatory Framework
- 6.6.7.3. Competitive Insights
- 6.6.7.4. Thailand Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7. Latin America
- 6.7.1. Latin America Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.7.2. Brazil
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Regulatory Framework
- 6.7.2.3. Competitive Insights
- 6.7.2.4. Brazil Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.3. Argentina
- 6.7.3.1. Key Country Dynamics
- 6.7.3.2. Regulatory Framework
- 6.7.3.3. Competitive Insights
- 6.7.3.4. Argentina Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.8. MEA
- 6.8.1. MEA Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.8.2. South Africa
- 6.8.2.1. Key Country Dynamics
- 6.8.2.2. Regulatory Framework
- 6.8.2.3. Competitive Insights
- 6.8.2.4. South Africa Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.8.3. Saudi Arabia
- 6.8.3.1. Key Country Dynamics
- 6.8.3.2. Regulatory Framework
- 6.8.3.3. Competitive Insights
- 6.8.3.4. Saudi Arabia Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.8.4. UAE
- 6.8.4.1. Key Country Dynamics
- 6.8.4.2. Regulatory Framework
- 6.8.4.3. Competitive Insights
- 6.8.4.4. UAE Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.8.5. Kuwait
- 6.8.5.1. Key Country Dynamics
- 6.8.5.2. Regulatory Framework
- 6.8.5.3. Competitive Insights
- 6.8.5.4. Kuwait Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Participant Overview
- 7.2. Company Market Position Analysis
- 7.3. Company Categorization
- 7.4. Strategy Mapping
- 7.5. Company Profiles/Listing
- 7.5.1. Bruker
- 7.5.1.1. Overview
- 7.5.1.2. Financial Performance
- 7.5.1.3. Product Benchmarking
- 7.5.1.4. Strategic Initiatives
- 7.5.2. PerkinElmer
- 7.5.2.1. Overview
- 7.5.2.2. Financial Performance
- 7.5.2.3. Product Benchmarking
- 7.5.2.4. Strategic Initiatives
- 7.5.3. MR Solutions
- 7.5.3.1. Overview
- 7.5.3.2. Financial Performance
- 7.5.3.3. Product Benchmarking
- 7.5.3.4. Strategic Initiatives
- 7.5.4. BioTek Instruments, Inc.
- 7.5.4.1. Overview
- 7.5.4.2. Financial Performance
- 7.5.4.3. Product Benchmarking
- 7.5.4.4. Strategic Initiatives
- 7.5.5. MILabs B.V.
- 7.5.5.1. Overview
- 7.5.5.2. Financial Performance
- 7.5.5.3. Product Benchmarking
- 7.5.5.4. Strategic Initiatives
- 7.5.6. Magnetic Insight, Inc.
- 7.5.6.1. Overview
- 7.5.6.2. Financial Performance
- 7.5.6.3. Product Benchmarking
- 7.5.6.4. Strategic Initiatives
- 7.5.7. MBF Bioscience
- 7.5.7.1. Overview
- 7.5.7.2. Financial Performance
- 7.5.7.3. Product Benchmarking
- 7.5.7.4. Strategic Initiatives
- 7.5.8. FUJIFILM Corporation
- 7.5.8.1. Overview
- 7.5.8.2. Financial Performance
- 7.5.8.3. Product Benchmarking
- 7.5.8.4. Strategic Initiatives
- 7.5.9. Mediso Ltd.
- 7.5.9.1. Overview
- 7.5.9.2. Financial Performance
- 7.5.9.3. Product Benchmarking
- 7.5.9.4. Strategic Initiatives